Old Web
English
Sign In
Acemap
>
authorDetail
>
Hollis D Kleinert
Hollis D Kleinert
Potency
Renin–angiotensin system
Enzyme
Medicine
Biochemistry
4
Papers
89
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion.
1999
American Journal of Cardiology
Paul S. Teirstein
J. Tift Mann
Paul E Cundey
Eliot Schechter
W.Carlisle Jacobs
Cindy L. Grines
David J Stagaman
Alexandra J. Lansky
Mitchell A Hultquist
Barry A Kusnick
Richard R. Heuser
Hollis D Kleinert
Jeffrey J. Popma
Show All
Source
Cite
Save
Citations (14)
Ex Vivo Inhibition of PAF-Induced β-Thromboglobulin Release in Man by ABT-299, a Potent PAF Antagonist
1996
Advances in Experimental Medicine and Biology
Daniel H. Albert
Terrance J. Magoc
Hollis D Kleinert
Eugene Sun
Ana E. Reyes
George W. Carter
James B. Summers
Show All
Source
Cite
Save
Citations (2)
Renin Inhibitors: Discovery and Development An Overview and Perspective
1989
American Journal of Hypertension
Hollis D Kleinert
Show All
Source
Cite
Save
Citations (10)
Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency
1988
Journal of Medicinal Chemistry
Luly
Nwe Y. Bamaung
Jeff Soderquist
Anthony K. L. Fung
Herman H. Stein
Hollis D Kleinert
P A Marcotte
David A. Egan
Barbara A. Bopp
Merits I
Show All
Source
Cite
Save
Citations (63)
1